Rein Therapeutics Inc.
RNTX
$1.76
-$0.15-7.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.87M | 17.65M | 21.92M | 12.04M | 17.31M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 252.00K | 1.22M | 697.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 792.00K | 780.00K | 25.00K | 25.00K | 953.00K |
| Total Current Assets | 13.66M | 18.68M | 23.16M | 12.76M | 18.27M |
|
|
|||||
| Total Current Assets | 13.66M | 18.68M | 23.16M | 12.76M | 18.27M |
| Net Property, Plant & Equipment | 1.00K | 1.00K | 2.00K | 6.00K | 19.00K |
| Long-term Investments | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M |
| Goodwill | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M |
| Total Other Intangibles | 42.20M | 79.20M | 79.20M | 79.20M | 79.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00K | 2.00K | 709.00K | 892.00K | 2.19M |
| Total Assets | 62.19M | 104.22M | 109.40M | 99.19M | 106.01M |
|
|
|||||
| Total Accounts Payable | 911.00K | 1.08M | 782.00K | 2.16M | 1.19M |
| Total Accrued Expenses | 4.72M | 4.51M | 3.90M | 2.10M | 2.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 48.00K |
| Total Finance Division Other Current Liabilities | 122.00K | 73.00K | 255.00K | 280.00K | 206.00K |
| Total Other Current Liabilities | 122.00K | 73.00K | 255.00K | 280.00K | 206.00K |
| Total Current Liabilities | 5.75M | 5.66M | 4.94M | 4.53M | 4.39M |
|
|
|||||
| Total Current Liabilities | 5.75M | 5.66M | 4.94M | 4.53M | 4.39M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.05M | 3.33M | 3.44M | 3.33M | 3.33M |
| Total Liabilities | 7.80M | 8.99M | 8.38M | 7.86M | 7.71M |
|
|
|||||
| Common Stock & APIC | 360.81M | 360.67M | 360.61M | 340.44M | 295.47M |
| Retained Earnings | -351.40M | -310.42M | -304.57M | -295.63M | -288.52M |
| Treasury Stock & Other | -18.00K | -26.00K | -22.00K | -63.00K | -63.00K |
| Total Common Equity | 9.39M | 50.23M | 56.02M | 44.75M | 6.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 45.01M | 45.01M | 45.01M | 46.58M | 91.41M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 45.01M | 45.01M | 45.01M | 46.58M | 91.41M |
|
|
|||||
| Total Common Equity | 9.39M | 50.23M | 56.02M | 44.75M | 6.89M |
| Total Preferred Equity | 45.01M | 45.01M | 45.01M | 46.58M | 91.41M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 54.39M | 95.23M | 101.02M | 91.33M | 98.30M |
|
|
|||||